Lobular panniculitis in rheumatic diseases: the authors’ own data
https://doi.org/10.14412/1996-7012-2020-1-57-61
Abstract
Objective: to study the clinical and laboratory features of lobular panniculitides (LPn) on a cohort of patients referred to the rheumatology center.
Patients and methods. The investigation enrolled 687 patients (613 women and 74 men; mean age, 39.7±11.3 and 41.2±12.5 years, respectively) with panniculitis (Pn) who had received outpatient and/or inpatient treatment for diagnosed erythema nodosum or panniculitis at the V.A. Nasonova Research Institute of Rheumatology in 2007–2017.
Results and discussion. By applying the diagnostic algorithm developed by the authors and the existing classification of Pn, the investigators diagnosed septal Pn in 430 (62.6%) patients and LPn in 249 (36.2%). The latter was associated with rheumatic diseases (RDs) in 97 (39%) patients. Most (70%) cases were patients with idiopathic LPn (ILPn), which, according to the 10th edition of the International Classification of Diseases, belongs to a group of systemic connective tissue disorders (M35.6), as well as those with systemic lupus erythematosus (SLE) (11.45%), dermatomyositis (DM) (9.37%), and rheumatoid arthritis (7%). This group showed a preponderance of females (the ratio of males to females was 1:7) with the chronic course of the disease mainly in ILPn. The clinical picture corresponded to four types of LPn, which may be of diagnostic and prognostic value in RDs.
Conclusion. This investigation confirmed the relevance of studying LPn in RDs because of its negative impact on the course, severity and therapeutic efficiency of the underlying disease.
About the Authors
O. N. Egorova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
B. S. Belov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
S. G. Radenska-Lopovok
V.A. Nasonova Research Institute of Rheumatology;
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522;
8, Trubetskaya St., Build. 2, Moscow 119991
References
1. Ter Poorten MC, Thiers BH. Panniculitis. Dermatol Clin. 2002;20(3):421-33. doi: 10.1016/S0733-8635(02)00008-6
2. Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001;45:163-83. doi: 10.1067/mjd.2001.114736
3. Requena L, Sanchez YuE. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001;45:325-61. doi: 10.1067/mjd.2001.114735
4. Wick MR. Panniculitis: а summary. Semin Diagn Pathol. 2017;34(3):261-72. doi: 10.1053/j.semdp.2016.12.004
5. Verbenko EV. Spontaneous panniculitis. In: Skripkin YuK, editor. Kozhnye i venericheskie bolezni. Rukovodstvo dlya vrachey [Skin and sexually transmitted diseases. Guide for doctors]. Moscow: Meditsina; 1995. Vol. 2. P. 399-410 (In Russ.).
6. Morita TCAB, Tres GFS, Garcia MSC, et al. Panniculitides of particular interest to the rheumatologist. Adv Rheumatol. 2019 Aug 1; 59(1):35. doi: 10.1186/s42358-019-0077-5
7. Egorova ON, Belov BC, Glukhova SI, Radenska-Lopovok SG. Idiopathic lobular panniculitis as a general clinical problem. Terapevticheskiy Arkhiv. 2019;91(5):49-53 (In Russ.).
8. Radenska-Lopovok SG, Egorova ON, Belov BS, et al. Features of idiopathic panniculitis – clinical and morphological correlations. Arkhiv Patologii. 2019;81(3):37-44 (In Russ.).
9. Egorova ON, Belov BS, Radenska-Lopovok SG, et al. To the problem of differential diagnosis of panniculitis. Vrach. 2014;(11): 14-9 (In Russ.).
10. Murazyan RI, Panchenkov NR. Ekstrennaya pomoshch' pri ozhogakh [Emergency burns]. Moscow: Meditsina; 1983. P. 63-4 (In Russ.).
11. Antelava OA, Nasonov EL Modern methods of assessment of activity and damage in idiopathic inflammatory myopathies. NauchnoPrakticheskaya Revmatologiya = Rheumatology Science and Practice. 2007;45(1):59-62 (In Russ.).
12. Kisacik B, Onat AM, Pehlivan Y. Multiclinical experiences in erythema nodosum: rheumatology clinics versus dermatology and infection diseases clinics. Rheumatol Int. 2013;33(2):315-8. doi: 10.1007/s00296-012-2413-5
13. Kimball H, Kimball D, Siroy A, et al. Novel diagnostic imaging features of facial lupus panniculitis: ultrasound, CT, and MR imaging with histopathology correlate. Clin Imaging. 2019 Jul;58:177-81. doi: 10.1016/j.clinimag.2019.07.006
14. Hansen CB, Callen JP. Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma. Dermatol Ther. 2010;23(4):341-49. doi: 10.1111/j.1529-8019.2010.01334.x
15. Beketova TV, Nasonov EL. Innovative treatments for Takayasu’s arteritis: A focus on interleukin-6 inhibitors. The authors’ experience with tocilizumab and a review of literature. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017; 55(5):536-48. doi: 10.14412/1995-4484-2017-536-548 (In Russ.).
16. Mangold AR, Costello CM, Cumsky HJL, et al. Systemic scleroderma and lupus panniculitis with atypical clinical features: A case report and comprehensive review. JAAD Case Rep. 2018 Sep;4(8):789-93. doi: 10.1016/ j.jdcr.2018.03.022
17. Kuhn A. Characterizing clinicopathological and immunohistochemical findings in dermatomyositis panniculitis. J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1231-32. doi: 10.1111/jdv.15149
Review
For citations:
Egorova ON, Belov BS, Radenska-Lopovok SG. Lobular panniculitis in rheumatic diseases: the authors’ own data. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2020;14(1):57-61. (In Russ.) https://doi.org/10.14412/1996-7012-2020-1-57-61
Views:
1228
Email this article 